Australia's most trusted
source of pharma news
Wednesday, 18 June 2025
Posted 6 June 2025 PM
News that Eli Lilly - the biggest pharma in the world by market cap, with a string of blockbuster drugs under its belt - had gone to market to hire new talent was our top read story this week.
The company is continuing to build its neuroscience team to support the launch of Kisunla, the first and only disease modifying therapy in Australia proven to delay cognitive and functional decline in people with early symptomatic Alzheimer's disease.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.